This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1991 Jan;34(1):60-1.

doi: 10.1007/BF00404028.

Glucose infusion rates during euglycaemic clamps do not precisely reflect action profiles of subcutaneously injected insulin

W Kerner, F S Keck, E F Pfeiffer

PMID: 2055344
DOI: 10.1007/BF00404028

Comment

Glucose infusion rates during euglycaemic clamps do not precisely reflect action profiles of subcutaneously injected insulin

W Kerner et al. Diabetologia. 1991 Jan.

. 1991 Jan;34(1):60-1.

doi: 10.1007/BF00404028.

Authors

W Kerner, F S Keck, E F Pfeiffer

PMID: 2055344
DOI: 10.1007/BF00404028

No abstract available

PubMed Disclaimer

Comment on

Action profiles of fast onset insulin analogues.
Heinemann L, Starke AA, Heding L, Jensen I, Berger M. Heinemann L, et al. Diabetologia. 1990 Jun;33(6):384-6. doi: 10.1007/BF00404644. Diabetologia. 1990. PMID: 2199281 Clinical Trial.

Similar articles

Action profiles of fast onset insulin analogues.
Heinemann L, Starke AA, Heding L, Jensen I, Berger M. Heinemann L, et al. Diabetologia. 1990 Jun;33(6):384-6. doi: 10.1007/BF00404644. Diabetologia. 1990. PMID: 2199281 Clinical Trial.
Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers.
Rave K, Heise T, Weyer C, Sawicki P, Heinemann L. Rave K, et al. Exp Clin Endocrinol Diabetes. 1999;107(5):313-7. doi: 10.1055/s-0029-1212118. Exp Clin Endocrinol Diabetes. 1999. PMID: 10482044 Clinical Trial.
Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin.
Heinemann L, Chantelau EA, Starke AA. Heinemann L, et al. Diabete Metab. 1992 Jan-Feb;18(1):21-4. Diabete Metab. 1992. PMID: 1563532
Euglycaemic glucose clamp: what it can and cannot do, and how to do it.
Heise T, Zijlstra E, Nosek L, Heckermann S, Plum-Mörschel L, Forst T. Heise T, et al. Diabetes Obes Metab. 2016 Oct;18(10):962-72. doi: 10.1111/dom.12703. Epub 2016 Jul 13. Diabetes Obes Metab. 2016. PMID: 27324560 Review.
Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
Roach P, Woodworth JR. Roach P, et al. Clin Pharmacokinet. 2002;41(13):1043-57. doi: 10.2165/00003088-200241130-00003. Clin Pharmacokinet. 2002. PMID: 12403642 Review.

See all similar articles

Cited by

How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers.
Liu H, Li T, Yu H, Li J, Tan H, Yu Y. Liu H, et al. Front Pharmacol. 2022 Jul 22;13:899798. doi: 10.3389/fphar.2022.899798. eCollection 2022. Front Pharmacol. 2022. PMID: 35935883 Free PMC article.

References

1. Diabetologia. 1990 Jun;33(6):384-6 - PubMed
1. Diabet Med. 1989 Apr;6(3):239-44 - PubMed
1. Diabetes. 1983 Jan;32(1):35-45 - PubMed
1. Diabetes. 1981 Oct;30(10):829-35 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information